Explore hypoparathyroidism research opportunities and learn how you can contribute to advancing treatment options
Clinical trials help researchers understand hypoparathyroidism better and develop new treatment options that could benefit millions of patients.
Your participation in clinical trials directly impacts the future of hypoparathyroidism treatment and helps create better care options for everyone.
Every patient who participates in research contributes to a stronger hypoparathyroidism community and helps us move closer to better treatments.
TRIAL IDENTIFIER
NCT05793853
STUDY TYPE
Natural History Study
PRINCIPAL INVESTIGATOR
Dr. Mishaela Ruth Rubin
This comprehensive natural history study examines the long-term complications and disease progression of hypoparathyroidism. The research helps physicians and patients understand the condition better and make informed decisions about treatment options, including whether conventional treatment with calcium and vitamin D is appropriate for individual patients.
As new treatment options like Yorvipath emerge, understanding the long-term complications of hypoparathyroidism is crucial. This study provides the evidence base that helps both physicians and patients make informed decisions about their care pathways and treatment strategies.
"This study is particularly important to the hypoparathyroidism community as it underscores the needed paradigm shift surrounding treatment and understanding of the condition. With new treatment options on the horizon, understanding the long-term complications can help both physicians and patients make informed decisions about their care pathways."
— Bari Vapnek
Director of Marketing and Public Relations, HypoPARAthyroidism Association, Inc.
TRIAL IDENTIFIER
NCT06961071
INSTITUTION
UCSF
STUDY TYPE
Clinical Research
This clinical trial at UCSF focuses on advancing hypoparathyroidism research and treatment options. The study aims to improve patient outcomes and expand our understanding of the condition.
UCSF's research contributes to the growing body of evidence supporting better treatment approaches for hypoparathyroidism patients. Your participation helps advance medical science and improve care options.
Review the study details on ClinicalTrials.gov to understand the research and eligibility criteria
Review the inclusion/exclusion criteria to determine if you qualify for the study
Reach out to the study team through ClinicalTrials.gov to express your interest in participating
Participate in the study and contribute to advancing hypoparathyroidism research and treatment options
This information is for educational purposes only and should not be considered medical advice. Always consult with your healthcare provider before participating in any clinical trial or making decisions about your treatment. If you experience a medical emergency, please call 911 or seek immediate medical attention.
Your participation in clinical trials can help advance hypoparathyroidism research and create better treatment options for patients worldwide.